These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3541517)

  • 1. Primary lipoprotein lipase deficiency.
    Brunzell JD; Iverius PH; Scheibel MS; Fujimoto WY; Hayden MR; McLeod R; Frolich J
    Adv Exp Med Biol; 1986; 201():227-39. PubMed ID: 3541517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The familial chylomicronemia syndrome.
    Santamarina-Fojo S
    Endocrinol Metab Clin North Am; 1998 Sep; 27(3):551-67, viii. PubMed ID: 9785052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial chylomicronemia syndrome.
    Sugandhan S; Khandpur S; Sharma VK
    Pediatr Dermatol; 2007; 24(3):323-5. PubMed ID: 17542893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An incomplete form of familial lipoprotein lipase deficiency presenting with type I hyperlipoproteinemia.
    Berger GM
    Am J Clin Pathol; 1987 Sep; 88(3):369-73. PubMed ID: 3630977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoprotein C-II deficiency].
    Inadera H
    Nihon Rinsho; 1994 Dec; 52(12):3241-5. PubMed ID: 7853717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chylomicronemia].
    Yamamoto T; Kawakami M
    Nihon Rinsho; 1990 Nov; 48(11):2526-31. PubMed ID: 2270016
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
    Martín-Campos JM; Julve J; Roig R; Martínez S; Errico TL; Martínez-Couselo S; Escolà-Gil JC; Méndez-González J; Blanco-Vaca F
    Clin Chim Acta; 2014 Feb; 429():61-8. PubMed ID: 24291057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation.
    Wilson DE; Emi M; Iverius PH; Hata A; Wu LL; Hillas E; Williams RR; Lalouel JM
    J Clin Invest; 1990 Sep; 86(3):735-50. PubMed ID: 2394828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome.
    Lam CW; Yuen YP; Cheng WF; Chan YW; Tong SF
    Clin Chim Acta; 2006 Feb; 364(1-2):256-9. PubMed ID: 16153625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of apoC-II and lipoprotein lipase deficiency.
    Fojo SS; de Gennes JL; Beisiegel U; Baggio G; Stalenhoef AF; Brunzell JD; Brewer HB
    Adv Exp Med Biol; 1991; 285():329-33. PubMed ID: 1858563
    [No Abstract]   [Full Text] [Related]  

  • 12. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.
    Heeren J; Niemeier A; Merkel M; Beisiegel U
    J Mol Med (Berl); 2002 Sep; 80(9):576-84. PubMed ID: 12226739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary lipoprotein lipase deficiency: clinical and genetic aspects].
    Murase T
    Nihon Rinsho; 1994 Dec; 52(12):3221-7. PubMed ID: 7853714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.
    Haberbosch W; Poli A; Baggio G; Fellin R; Gnasso A; Augustin J
    Biochim Biophys Acta; 1984 Mar; 793(1):49-60. PubMed ID: 6704413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of lipoprotein lipase and hepatic triglyceride lipase.
    Jackson RL; McLean LR; Ponce E; Rechtin A; Demel RA
    Adv Exp Med Biol; 1987; 210():73-7. PubMed ID: 3591558
    [No Abstract]   [Full Text] [Related]  

  • 16. [Familial hyperchylomicronemia syndrome].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():13-21. PubMed ID: 11347044
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease.
    Frohlich J; Godin DV
    Clin Biochem; 1986 Aug; 19(4):229-34. PubMed ID: 3019588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial commentary: Dietary management of familial chylomicronemia syndrome.
    Williams L; Wilson DP
    J Clin Lipidol; 2016; 10(3):462-5. PubMed ID: 27206931
    [No Abstract]   [Full Text] [Related]  

  • 19. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of adolescent hyperlipoproteinemia with xanthoma and acute pancreatitis, associated with decreased activities of lipoprotein lipase and hepatic triglyceride lipase.
    Fujita K; Maeda N; Kozawa J; Murano K; Okita K; Iwahashi H; Kihara S; Ishigami M; Omura M; Nakamura T; Shirai K; Yamamura T; Funahashi T; Shimomura I
    Intern Med; 2010; 49(22):2467-72. PubMed ID: 21088351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.